rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2010-11-30
|
pubmed:abstractText |
Preoperative biomarkers serum CEA and plasma TIMP-1 have been shown to have prognostic and predictive value in patients with colorectal cancer. The aim of the present study was to evaluate the possible impact of chemoradiotherapy (CRT) on preoperative biomarker levels in patients with rectal cancer.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1791-7530
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4755-9
|
pubmed:meshHeading |
pubmed-meshheading:21115936-Adenocarcinoma,
pubmed-meshheading:21115936-Adult,
pubmed-meshheading:21115936-Aged,
pubmed-meshheading:21115936-Aged, 80 and over,
pubmed-meshheading:21115936-Carcinoembryonic Antigen,
pubmed-meshheading:21115936-Combined Modality Therapy,
pubmed-meshheading:21115936-Female,
pubmed-meshheading:21115936-Follow-Up Studies,
pubmed-meshheading:21115936-Humans,
pubmed-meshheading:21115936-Male,
pubmed-meshheading:21115936-Middle Aged,
pubmed-meshheading:21115936-Neoplasm Recurrence, Local,
pubmed-meshheading:21115936-Neoplasm Staging,
pubmed-meshheading:21115936-Preoperative Care,
pubmed-meshheading:21115936-Prospective Studies,
pubmed-meshheading:21115936-Radiotherapy Dosage,
pubmed-meshheading:21115936-Rectal Neoplasms,
pubmed-meshheading:21115936-Survival Rate,
pubmed-meshheading:21115936-Tissue Inhibitor of Metalloproteinase-1,
pubmed-meshheading:21115936-Treatment Outcome,
pubmed-meshheading:21115936-Tumor Markers, Biological
|
pubmed:year |
2010
|
pubmed:articleTitle |
Chemoradiation-induced changes in serum CEA and plasma TIMP-1 in patients with locally advanced rectal cancer.
|
pubmed:affiliation |
Department of Surgery, Hillerød Hospital, DK-3400 Hillerød, Denmark. bal@noh.regionh.dk
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|